Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
249.37
-7.15 (-2.79%)
Aug 11, 2026, 12:43 PM EDT - Market open
Jazz Pharmaceuticals (JAZZ) Oncology Revenue Breakdown
| Date | Zepzelca | Rylaze Enrylaze | Defitellio Defibtrotide | Modeyso | Vyxeos | Erwinaze |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | 376.54M | 411.23M | 220.02M | 137.17M | 130.31M | - |
| Mar 31, 2026 | 345.28M | 412.39M | 206.13M | 88.97M | 143.77M | - |
| Dec 31, 2025 | 307.31M | 402.92M | 199.39M | 47.57M | 146.71M | - |
| Sep 30, 2025 | 295.20M | 396.25M | 198.17M | 11.03M | 165.23M | - |
| Jun 30, 2025 | 301.75M | 395.16M | 212.24M | - | 161.96M | - |
| Mar 31, 2025 | 308.25M | 402.33M | 209.55M | - | 160.12M | - |
| Dec 31, 2024 | 320.32M | 410.85M | 216.57M | - | 162.60M | - |
| Sep 30, 2024 | 316.00M | 411.11M | 210.00M | - | 156.26M | - |
| Jun 30, 2024 | 308.15M | 417.19M | 191.91M | - | 151.77M | - |
| Mar 31, 2024 | 297.45M | 411.05M | 192.60M | - | 142.82M | - |
| Dec 31, 2023 | 289.53M | 394.23M | 184.00M | - | 147.50M | - |
| Sep 30, 2023 | 287.49M | 373.45M | 173.57M | - | 130.85M | - |
| Jun 30, 2023 | 279.82M | 342.11M | 175.29M | - | 131.09M | - |
| Mar 31, 2023 | 277.76M | 313.37M | 183.88M | - | 130.92M | - |
| Dec 31, 2022 | 269.91M | 281.66M | 194.29M | - | 127.98M | - |
| Sep 30, 2022 | 262.78M | 265.64M | 196.15M | - | 132.48M | - |
| Jun 30, 2022 | 264.17M | 212.80M | 204.40M | - | 137.10M | - |
| Mar 31, 2022 | 251.81M | 139.85M | 197.80M | - | 134.66M | 28.31M |
| Dec 31, 2021 | 246.81M | 85.63M | 197.93M | - | 134.06M | 69.38M |
| Sep 30, 2021 | 235.41M | 20.67M | 210.88M | - | 130.29M | 125.96M |